Research Article

Procyanidins Extracted from Lotus Seedpod Ameliorate Amyloid-β-Induced Toxicity in Rat Pheochromocytoma Cells

Table 1

Quantities of compounds in rat tissues of control and LSPC groups.
(a)

Compound (ng/g)BrainCardiacLiver
ControlLSPCControlLSPCControlLSPC
Mean ± SEMMean ± SEMMean ± SEMMean ± SEMMean ± SEMMean ± SEM

PDBNDNDNDNDNDND
ECGNDNDNDNDNDND
EGCNDNDNDNDNDND
Quercetin35.84 ± 2.6346.72 ± 2.5729.29 ± 1.5440.96 ± 2.5427.71 ± 1.4549.12 ± 3.63
CatechinNDNDND7.96 ± 3.47ND7.59 ± 6.59
EpicatechinND82.36 ± 7.79ND66.36 ± 31.51ND55.50 ± 9.13∗∗∗
Syringic acidNDNDNDNDNDND
Ferulic acid54.21 ± 3.8184.45 ± 8.96NDNDNDND
HVA142.07 ± 12.50236.36 ± 63.98NDND1.52 ± 0.9419.36 ± 2.53
Caffeic acid109.07 ± 3.95120.93 ± 5.7386.50 ± 1.7096.00 ± 3.5779.50 ± 1.7092.50 ± 4.98
Gallic acid39.88 ± 2.8369.36 ± 4.7212.44 ± 1.4420.48 ± 3.3017.74 ± 3.1530.13 ± 4.09
Vanillic acid67.92 ± 11.19122.50 ± 17.15NDNDNDND
3,4-DHPA154.21 ± 22.81361.71 ± 162.6618.64 ± 1.9221.89 ± 2.08NDND
p-HPPA14.29 ± 2.7522.29 ± 3.6622.31 ± 13.309.43 ± 3.248.99 ± 6.4128.09 ± 7.20
m-Coumaric acid9.26 ± 0.9813.20 ± 0.97NDNDNDND
PCC183.64 ± 11.80231.29 ± 16.06211.21 ± 12.03279.43 ± 40.98112.14 ± 6.73152.93 ± 19.14
3-HPAA16.03 ± 1.1625.47 ± 2.6518.81 ± 0.7726.89 ± 3.00104.00 ± 9.17170.86 ± 13.76
3-HBA58.11 ± 12.8783.49 ± 38.0210.53 ± 4.378.26 ± 1.81ND4.13 ± 0.73
Pyrocatechol94.21 ± 5.88124.79 ± 9.4954.54 ± 2.6663.49 ± 5.2713.46 ± 1.9421.16 ± 2.92

(b)

Compound (ng/g)KidneySpleenPancreas
ControlLSPCControlLSPCControlLSPC
Mean ± SEMMean ± SEMMean ± SEMMean ± SEMMean ± SEMMean ± SEM

PDBNDNDNDNDNDND
ECGNDNDNDNDNDND
EGCNDNDNDNDNDND
Quercetin20.40 ± 1.2749.55 ± 2.9929.13 ± 1.5638.49 ± 3.6617.55 ± 6.2350.78 ± 3.15
CatechinND7.01 ± 1.66NDNDNDND
EpicatechinND32.40 ± 4.37ND33.71 ± 21.76NDND
Syringic acidNDNDNDNDNDND
Ferulic acidNDNDNDND18.49 ± 7.8641.51 ± 3.58
HVA14.46 ± 3.3173.71 ± 9.05NDNDNDND
Caffeic acid71.00 ± 2.25101.50 ± 5.9051.88 ± 2.6052.31 ± 2.93114.43 ± 6.23126.86 ± 7.82
Gallic acid25.64 ± 1.3551.12 ± 17.2922.47 ± 1.6926.72 ± 1.1630.32 ± 5.5847.08 ± 1.43
Vanillic acidND21.83 ± 7.41NDND23.72 ± 6.3344.05 ± 7.34
3,4-DHPA9.34 ± 1.8320.89 ± 2.459.19 ± 2.4819.31 ± 1.24NDND
p-HPPA85.69 ± 61.94279.71 ± 67.665.65 ± 2.7412.77 ± 3.75NDND
m-Coumaric acidND20.05 ± 13.39NDND17.88 ± 3.7136.21 ± 4.51
PCC118.43 ± 10.88134.29 ± 8.74145.71 ± 16.17152.14 ± 17.77216.86 ± 17.69229.21 ± 12.45
3-HPAA15.31 ± 1.3721.62 ± 3.212.82 ± 1.112.14 ± 0.7340.83 ± 3.5649.78 ± 4.52
3-HBA5.40 ± 0.6826.16 ± 2.603.12 ± 0.874.29 ± 0.99NDND
Pyrocatechol19.98 ± 1.6733.25 ± 3.6016.56 ± 2.8416.81 ± 3.7869.26 ± 5.0670.64 ± 3.89

Note: control and LSPC represent different intervention groups, respectively. PDB, ECG, EGC, HVA, 3,4-DHPA, p-HPPA, PCC, 3-HPAA, and 3-HBA stand for procyanidin dimer B, epicatechin gallate, epigallocatechin, homovanillic acid, 3,4-dihydroxyphenylacetic acid, 3-(4-hydroxyphenyl)propionic acid, protocatechuic acid, 3-hydroxyphenylacetic acid, and 3-hydroxybenzoic acid, respectively. Values represent the concentrations of metabolites in different rat tissues, and they were all presented as the means ± SEM (); ND = not detected; , , indicates significant differences between two groups with or without LSPC (, , and ), respectively.